Literature DB >> 28282648

Geospatial Planning and the Resulting Economic Impact of Human Papillomavirus Vaccine Introduction in Mozambique.

Leila A Haidari1, Shawn T Brown, Dagna Constenla, Eli Zenkov, Marie Ferguson, Gatien de Broucker, Sachiko Ozawa, Samantha Clark, Allison Portnoy, Bruce Y Lee.   

Abstract

BACKGROUND: Research has shown that the distance to the nearest immunization location can ultimately prevent someone from getting immunized. With the introduction of human papillomavirus (HPV) vaccine throughout the world, a major question is whether the target populations can readily access immunization.
METHODS: In anticipation of HPV vaccine introduction in Mozambique, a country with a 2015 population of 25,727,911, our team developed Strategic Integrated Geo-temporal Mapping Application) to determine the potential economic impact of HPV immunization. We quantified how many people in the target population are reachable by the 1377 existing immunization locations, how many cannot access these locations, and the potential costs and disease burden averted by immunization.
RESULTS: If the entire 2015 cohort of 10-year-old girls goes without HPV immunization, approximately 125 (111-139) new cases of HPV 16,18-related cervical cancer are expected in the future. If each health center covers a catchment area with a 5-km radius (ie, if people travel up to 5 km to obtain vaccines), then 40% of the target population could be reached to prevent 50 (44-55) cases, 178 (159-198) disability-adjusted life years, and US $202,854 (US $140,758-323,693) in health care costs and lost productivity. At higher catchment area radii, additional increases in catchment area radius raise population coverage with diminishing returns.
CONCLUSIONS: Much of the population in Mozambique is unable to reach any existing immunization location, thereby reducing the potential impact of HPV vaccine. The geospatial information system analysis can assist in planning vaccine introduction strategies to maximize access and help the population reap the maximum benefits from an immunization program.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28282648      PMCID: PMC5547744          DOI: 10.1097/OLQ.0000000000000574

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  19 in total

Review 1.  Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program.

Authors:  Proma Paul; Anthony Fabio
Journal:  Vaccine       Date:  2013-12-02       Impact factor: 3.641

Review 2.  Health sector priority setting at meso-level in lower and middle income countries: lessons learned, available options and suggested steps.

Authors:  David B Hipgrave; Katarzyna Bolsewicz Alderman; Ian Anderson; Eliana Jimenez Soto
Journal:  Soc Sci Med       Date:  2013-12-10       Impact factor: 4.634

3.  Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa.

Authors:  Nicole G Campos; Jane J Kim; Philip E Castle; Jesse D Ortendahl; Meredith O'Shea; Mireia Diaz; Sue J Goldie
Journal:  Int J Cancer       Date:  2011-08-24       Impact factor: 7.396

4.  Alternative vaccination locations: who uses them and can they increase flu vaccination rates?

Authors:  Bruce Y Lee; Ateev Mehrotra; Rachel M Burns; Katherine M Harris
Journal:  Vaccine       Date:  2009-05-09       Impact factor: 3.641

5.  Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States.

Authors:  Jane J Kim; Jesse Ortendahl; Sue J Goldie
Journal:  Ann Intern Med       Date:  2009-10-20       Impact factor: 25.391

6.  Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.

Authors:  Sue J Goldie; Meredith O'Shea; Nicole Gastineau Campos; Mireia Diaz; Steven Sweet; Sun-Young Kim
Journal:  Vaccine       Date:  2008-05-15       Impact factor: 3.641

Review 7.  Human papillomavirus vaccine introduction--the first five years.

Authors:  Lauri E Markowitz; Vivien Tsu; Shelley L Deeks; Heather Cubie; Susan A Wang; Andrea S Vicari; Julia M L Brotherton
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

8.  Sociodemographic factors associated with high-risk human papillomavirus infection.

Authors:  Jessica A Kahn; Dongmei Lan; Robert S Kahn
Journal:  Obstet Gynecol       Date:  2007-07       Impact factor: 7.661

Review 9.  The cost effectiveness of human papillomavirus vaccines: a systematic review.

Authors:  Katherine Seto; Fawziah Marra; Adam Raymakers; Carlo A Marra
Journal:  Drugs       Date:  2012-03-26       Impact factor: 11.431

10.  Web-based public health geographic information systems for resources-constrained environment using scalable vector graphics technology: a proof of concept applied to the expanded program on immunization data.

Authors:  Raoul Kamadjeu; Herman Tolentino
Journal:  Int J Health Geogr       Date:  2006-06-03       Impact factor: 3.918

View more
  3 in total

1.  Using Simulation Modeling to Guide the Design of the Girl Scouts Fierce & Fit Program.

Authors:  Marie C Ferguson; Matthew J Morgan; Kelly J O'Shea; Lucas Winch; Sheryl S Siegmund; Mario Solano Gonzales; Samuel Randall; Daniel L Hertenstein; Valerie Montague; Ayanna Woodberry; Trish Cassatt; Bruce Y Lee
Journal:  Obesity (Silver Spring)       Date:  2020-05-07       Impact factor: 5.002

2.  A systems map of the economic considerations for vaccination: Application to hard-to-reach populations.

Authors:  Sarah N Cox; Patrick T Wedlock; Sarah W Pallas; Elizabeth A Mitgang; Tatenda T Yemeke; Sarah M Bartsch; Taiwo Abimbola; Sheryl S Sigemund; Aaron Wallace; Sachiko Ozawa; Bruce Y Lee
Journal:  Vaccine       Date:  2021-05-25       Impact factor: 3.641

3.  High-resolution disease maps for cancer control in low-resource settings: A spatial analysis of cervical cancer incidence in Kampala, Uganda.

Authors:  Kirsten Beyer; Simon Kasasa; Ronald Anguzu; Robert Lukande; Sarah Nambooze; Phoebe M Amulen; Yuhong Zhou; Brendah Nansereko; Courtney Jankowski; Tonny Oyana; Danielle Savino; Kavanya Feustel; Henry Wabinga
Journal:  J Glob Health       Date:  2022-04-23       Impact factor: 4.413

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.